Delivery Order SPE2DB24D2106-SPE2DB24FAUEZ
Award Date 5/9/24
Potential Completion Date 5/10/24
Potential Value $30K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $22,713.49, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a delivery order for the provision of OTEZLA 30 MG TABLET 60S, a specialized pharmaceutical product, with a period of performance that extends to January 9, 2025. DMS Pharmaceutical Group Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This federal contract award is a $5,435.86 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Otezla 30 mg tablets, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
- The U.S. Defense Logistics Agency (DLA) awarded a $25,679.07 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the supply of 60-count bottles of Otezla 30 mg tablets, a pharmaceutical product used to treat certain medical conditions. This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract SPE2DB24D2106 with DLA, which has a ceiling value of up to $4,999,999 and enables...
- This federal contract award, valued at $45,987.19, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is a firm fixed-price delivery order (SPE2DB24D2106|SPE2DB24FAUKV) for the provision of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $5,241.08, is for the delivery of Otezla 30 mg tablets. It is not associated with a set-aside designation. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, received a delivery order award from the Defense Logistics Agency (DLA) on June 3, 2025, for 60-count tablets of Otezla 30 mg, with a ceiling value of $19,042.16. This firm fixed-price delivery order, without set-aside designation, is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $22,541.73 by the Defense Logistics Agency on September 9, 2025, for the supply of Otezla 30 mg tablets (60-count packages). The delivery order, which carries no set-aside designation, is scheduled for completion by September 10, 2025, with performance occurring in Conshohocken, Pennsylvania. This award represents a task...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $7,243.22 contract is for the delivery of 60 tablets of OTEZLA 30 mg, a prescription medication. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the...
- This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract has a ceiling value of $4,092.62 and covers the delivery of the pharmaceutical product "OTEZLA 30 MG TABLET 60S" with a period of performance through May 6, 2024. The DLA SPE2DB program is a single-award indefinite delivery contract (IDC) valued at up to...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Otezla 30 mg tablets (60 count) valued at $8,067.46 under a firm fixed-price contract type. The award was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and does not utilize a set-aside designation. DMS Pharmaceutical Group, based in Park Ridge, Illinois, will perform this delivery order from its Conshohocken,...